How to ensure that people don’t fall sick?
Measures taken for prevention in healthcare
We know for a fact that…
11.3% of Singaporeans (around 1 in 10) aged 18 to 69 have diabetes *
USD 2,932.9 cost per person with Diabetes *
Of the deaths of adults aged 15-59 years, 23% are linked to heart diseases **
Of the deaths of adults aged 15-59 years, 37% are linked to cancer **
There were 12,700 dengue cases in Singapore in 2016 ***
How can we address these challenges together?
Starts at the individual level with a responsible behaviour to mitigate exposure within a social group
To control risk factors for healthy living
Early diagnostic & regular screenings
First end data to detect health issues
For controlling the spread of infectious diseases
Preventive care means for us intervening very early in a life in individual in order to prevent being affected by diseases. Either before getting sick or developing conditions such as chronic diseases.
Our strength is in developing products and services that support organisations and healthcare providers with the right diagnostic tools, education materials, nutrition and investments support.
Because we believe that one of the most important way for preventive care consists in education and training people behaviour.
A comprehensive offer
Healthy Lifestyle App
Investments in Food
Meet the players involved in this cluster
Building on the launch of the Smart Health platform, an initiative by the French Chamber of Commerce in Singapore, the Smart Health Summit held on 28 May 2019 themed "Understanding the Health Revolution", brought together a great range of 300 actors in the healthcare...
AXA Insurance unveiled today its new brand campaign that aims to empower people in Singapore to know they can “Rewrite the Rules” and reflects its global transformation from being a claims payer to being an encouraging partner to its customers. The local...
bioMérieux acquires a majority stake in Hybiome and strengthens its presence both in China and in the immunoassay market
bioMérieux, a world leader in the field of in vitro diagnostics, today announces the acquisition of a majority holding in Suzhou Hybiome Biomedical Engineering Co.Ltd. This announcement follows the acquisition of a minority stake in July 2018. Founded in 2009...
bioMérieux reinforces its offering of High Medical Value immunoassay biomarkers with the acquisition of Astute Medical
bioMérieux, a world leader in the field of in vitro diagnostics, announces today the acquisition of Astute Medical Inc., a company dedicated to improving the diagnosis of high-risk medical conditions and diseases through the identification and validation of protein...